Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingqiang Wang

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Plos One|January 10, 2014
Radiofrequency ablation versus hepatic resection for small hepatocellular carcinomas: a meta-analysis of randomized and nonrandomized controlled trialsYingqiang Wang, Qianqian Luo, Youping Li, et al.
Plos One|August 9, 2014
Quality assessment of clinical practice guidelines on the treatment of hepatocellular carcinoma or metastatic liver cancerYingqiang Wang, Qianqian Luo, Youping Li, et al.
BMJ (Clinical Research Ed.)|February 19, 2016
Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studiesLing Li, Sheyu Li, Ke Deng, et al.
BMC Cardiovascular Disorders|May 13, 2016
Glucagon-like peptide-1 receptor agonists and heart failure in type 2 diabetes: systematic review and meta-analysis of randomized and observational studiesLing Li, Sheyu Li, Jiali Liu, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Plos One|January 10, 2014
Radiofrequency ablation versus hepatic resection for small hepatocellular carcinomas: a meta-analysis of randomized and nonrandomized controlled trialsYingqiang Wang, Qianqian Luo, Youping Li, et al.
Plos One|August 9, 2014
Quality assessment of clinical practice guidelines on the treatment of hepatocellular carcinoma or metastatic liver cancerYingqiang Wang, Qianqian Luo, Youping Li, et al.
BMJ (Clinical Research Ed.)|February 19, 2016
Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studiesLing Li, Sheyu Li, Ke Deng, et al.
BMC Cardiovascular Disorders|May 13, 2016
Glucagon-like peptide-1 receptor agonists and heart failure in type 2 diabetes: systematic review and meta-analysis of randomized and observational studiesLing Li, Sheyu Li, Jiali Liu, et al.
Pageof 2